Warburgia salutaris (Warburgia salutaris): Benefits, Dosage, Safety & Evidence

Frequently asked questions

How does Warburgia salutaris work as an antimicrobial herb?

Warburgia salutaris contains bioactive sesquiterpene dialdehydes, particularly warburganal, polygodial, and muzigadial, which demonstrate antimicrobial activity. These compounds appear to disrupt microbial cell membranes, making them effective against various bacteria, fungi, and parasites. The bark also contains tannins with astringent properties that may support tissue healing. Evidence level C indicates these mechanisms are supported by preliminary research and traditional use, though more clinical studies are needed.

Can Warburgia salutaris interact with HIV medications or other drugs?

Limited formal drug interaction studies exist for Warburgia salutaris (Evidence level C). Due to potential effects on liver metabolism, caution is advised when taking this herb alongside antiretroviral medications or other drugs processed by the liver. The herb is contraindicated in liver disease. Patients on prescription medications, particularly those managing HIV, should consult a qualified healthcare provider before adding Warburgia salutaris to their regimen.

What is the recommended dosage for Warburgia salutaris bark?

Traditional and practitioner recommendations suggest 2-5 grams of dried bark prepared as a tea, or 1-2ml of tincture daily for adults (Evidence level C). Dosage should be divided throughout the day and taken with food to minimize potential gastrointestinal irritation. Starting with lower doses is advisable to assess tolerance. Higher doses may cause stomach upset. Consult a qualified medical herbalist for personalized dosing guidance.

Is Warburgia salutaris safe to take during pregnancy?

Warburgia salutaris is contraindicated during pregnancy and should not be used (Evidence level D). The sesquiterpene dialdehydes present in the bark may stimulate uterine contractions or cause fetal harm. Breastfeeding women should also avoid this herb due to insufficient safety data. Women of childbearing age should use reliable contraception while taking this herb and discontinue use immediately if pregnancy is suspected.

What is Warburgia salutaris used for in traditional medicine?

Warburgia salutaris bark is highly valued in Zulu, Swati, and Tsonga traditional medicine for treating respiratory infections, malaria, stomach disorders, and fever (Evidence level C). Some traditional practitioners use it as supportive therapy for HIV. The antimicrobial and anti-inflammatory properties of compounds like warburganal support these applications. The tree is endangered due to high demand, making sustainable sourcing essential.

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Warburgia salutaris, known as 'Pepper bark', is an ethnomedicinally important tree native to southern Africa used for its antimicrobial, anti-inflammatory, and anti-aging properties [PMID:33231346, PMID:35288287, PMID:37895122].

Background

Warburgia salutaris (family Canellaceae) is a medicinal tree found in the southern regions of Africa [PMID:33231346, PMID:35288287]. It is currently listed as Endangered on the IUCN Red List due to illegal harvesting of its bark and habitat degradation [PMID:33184322, PMID:11025153].

Traditional uses

Traditionally used as an expectorant, smoked for coughs and colds, and applied topically for sores and inflammation [PMID:11025153]. It is also used for treating skin complaints, malaria, and in ethnoveterinary practices to treat livestock diseases [PMID:35288287, PMID:19171185]. In Uganda, it is used by traditional medicine practitioners to treat tuberculosis and related ailments [PMID:19799983].

Active compounds

Major constituents of leaf essential oils include myrcene, (E)-β-ocimene, (Z)-β-ocimene, α-pinene, and limonene [PMID:33231346]. Identified bioactive compounds include sesquiterpenoids such as muzigadial [PMID:11025153], iso-mukaadial acetate [PMID:30111328, PMID:31546691], and 11alpha-hydroxycinnamosmolide [PMID:17368035]. Other reported compounds include ursolic acid and ursolic acid acetate [PMID:35022913], as well as neophytadiene, guanosine, squalene, cis megastigma-5,8-diene-4-one, and sorbitol [PMID:35520625].

Mechanism of action

The compound 11alpha-hydroxycinnamosmolide inhibits recombinant arylamine N-acetyltransferase (NAT), an enzyme involved in mycobacterial cell wall lipid synthesis [PMID:17368035]. Extracts have demonstrated the ability to inhibit pro-inflammatory cytokines (IL-1β, IL-6, TNF-α, IFN-γ) and the activation of nuclear factor-kappaB [PMID:19244290, PMID:38310564]. Iso-mukaadial acetate has been shown to enhance glucose uptake in rat myoblast cells [PMID:31546691] and upregulate genes linked to parasite biological processes and cell adhesion in P. falciparum [PMID:41309744].

Clinical evidence

Evidence DBacterial Infections

Extracts show antibacterial activity against Gram-positive bacteria, Escherichia coli, and Proteus species [PMID:11025153, PMID:9147258, PMID:23877712].

Evidence DTuberculosis

Extracts and purified compounds exhibit anti-mycobacterial activity against Mycobacterium tuberculosis H37Rv and Mycobacterium bovis BCG [PMID:17368035].

Evidence DMalaria

Iso-mukaadial acetate from stem bark demonstrated in vitro anti-plasmodial activity and in vivo efficacy in infected rats [PMID:30111328].

Evidence DBreast Cancer (MCF-7 cells)

Leaf extracts exhibit antiproliferative and pro-apoptotic effects in a time- and dose-dependent manner [PMID:40869386, PMID:42074205].

Evidence DInflammation

Ethanol leaf extracts demonstrated significant inhibitory activity (over 50-fold) against IL-1β, IL-6, and TNF-α in LPS-stimulated macrophages [PMID:38310564].

Evidence BGastrointestinal Nematodes (Sheep)

Evidence summary

The current evidence is primarily based on in vitro, in silico, and animal model studies (Level D), with one randomized controlled trial in sheep (Level B). There is a lack of human clinical trial data.

PubMed sources

1.PMID: 37895122 (2023) — Plant Extracts as Skin Care and Therapeutic Agents. · International journal of molecular sciences
2.PMID: 33231346 (2020) — Essential Oil Variation within Warburgia salutaris-A Coveted Ethnomedicinal Aromatic Tree. · Chemistry & biodiversity
3.PMID: 35288287 (2022) — Antioxidant and anti-aging effects of Warburgia salutaris bark aqueous extract: Evidences from in silico, in vitro and in vivo studies. · Journal of ethnopharmacology
4.PMID: 33184322 (2020) — The genetic legacy of fragmentation and overexploitation in the threatened medicinal African pepper-bark tree, Warburgia salutaris. · Scientific reports
5.PMID: 11025153 (2000) — Isolation of an antibacterial sesquiterpenoid from Warburgia salutaris. · Journal of ethnopharmacology

Warburgia salutaris

Sources & Citations

Calculate a safe dose of Warburgia salutaris